Research Article
Clinical Outcomes Based on the Attainment of Low-Density Lipoprotein Cholesterol Targets in Patients with Acute Coronary Syndrome in Real-World Practice
Figure 3
Kaplan–Meier curves analysis for CV mortality in patients with hypertension, DM, ESRD, and prior stroke between the patients with and without ≥50% reduced LDL-C levels during the 3-yearfollow-up period. (a) In the subgroup of hypertension, a lower incidence of CV mortality was noted in patients with ≥50% reduced LDL-C levels at the 3-yearfollow-up period (with vs. without; 1-year: 2.0% vs. 2.4%; ; 2-year: 3.8% vs. 4.5%; ; 3-year: 4.7% vs. 6.1%; ). (b) In the subgroup of DM, the incidence of CV mortality did not differ between the patients with and without ≥50% reduced LDL-C levels at the 3-yearfollow-up period (with vs. without; 1-year: 2.1% vs. 2.6%; ; 2-year: 4.4% vs. 4.7%; ; 3-year: 5.4% vs. 6.5%; ). (c) In the subgroup of ESRD, the incidence of CV mortality did not differ between the patients with and without a lowered LDL-C level (≥50%) at the 3-yearfollow-up period (with vs. without; 1-year: 5.4% vs. 5.4%; ; 2-year: 8.1% vs. 8.5%; ; 3-year: 8.6% vs. 10.2%; ). (d) In the subgroup of patients with a prior stroke, the incidence of CV mortality did not differ between the patients with and without ≥50% reduced LDL-C levels at the 3-yearfollow-up period (with vs. without; 1-year: 2.7% vs. 3.7%; ; 2-year: 4.6% vs. 6.7%; ; 3-year: 8.0% vs. 9.2%; ).
(a) |
(b) |
(c) |
(d) |